This inventor holds 2 USPTO granted patents and 2 published patent applications and 2 EPO patents. Top assignees: In Situ Rcp A/s, Olink Ab. Active years: 2011.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2011
Title: Jakob Schwalbe Lohmann: Innovator in Oligonucleotide Production
Introduction
Jakob Schwalbe Lohmann is a notable inventor based in Ry, Denmark. He has made significant contributions to the field of oligonucleotide production, holding 2 patents that showcase his innovative approaches. His work focuses on enhancing the efficiency and effectiveness of oligonucleotide synthesis and detection.
Latest Patents
Lohmann's latest patents include methods for the production of oligonucleotides using rolling circle replication. This invention allows for the synthesis of multimeric oligonucleotides, which can be reduced to mononucleotides using a nicking cassette. This method enables efficient amplification of oligonucleotides up to lengths of at least 1000 nucleotides, providing high yields contained within a nicking cassette. Another significant patent involves circle probes and their use in the identification of biomolecules. This invention provides oligonucleotides and methods for the efficient detection of target nucleic acids, allowing for circularization without an external ligation template. The oligonucleotides generated can create a free 3' end of the target nucleic acid necessary for rolling circle replication, making them valuable as research tools and for diagnostic purposes.
Career Highlights
Throughout his career, Lohmann has worked with several companies, including In Situ Rcp A/S and Olink AB. His experience in these organizations has contributed to his expertise in the field of biotechnology and oligonucleotide research.
Collaborations
Lohmann has collaborated with notable professionals in his field, including Jorn Erland Koch and Magnus Stougaard. These collaborations have likely enriched his research and development efforts.
Conclusion
Jakob Schwalbe Lohmann is a prominent figure in the innovation of oligonucleotide production and detection methods. His patents reflect a commitment to advancing biotechnology, making significant contributions to research and diagnostics.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile